Back
Anavex Life Sciences Vs. SELLAS Life Sciences Group Industry Stock Comparison
Buy
55
AVXL
Anavex Life Sciences
Last Price:
9.09
Seasonality Move:
12.07%
Sell
47
SLS
SELLAS Life Sciences Group
Last Price:
1.17
Seasonality Move:
12%
Buy
55
Anavex Life Sciences (AVXL)
is a Buy
Is Anavex Life Sciences a Buy, Sell or Hold?
- The current Anavex Life Sciences [AVXL] share price is $9.11. The Score for AVXL is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- AVXL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
SELLAS Life Sciences Group (SLS)
is a Sell
Is SELLAS Life Sciences Group a Buy, Sell or Hold?
- The current SELLAS Life Sciences Group [SLS] share price is $1.17. The Score for SLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- SLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AVXL Stock Price Chart
What is Anavex Life Sciences's stock price today?
-
The Anavex Life Sciences share price today is $9.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AVXL is experiencing buying pressure, which is a positive indicator for future bullish movement.
SLS Stock Price Chart
What is SELLAS Life Sciences Group's stock price today?
-
The SELLAS Life Sciences Group share price today is $1.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLS is experiencing selling pressure, which indicates risk of future bearish movement.
AVXL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.72 | Buy |
| Relative Strength Index (14 RSI): | 68.53 | Buy |
| Chaikin Money Flow: | 1378097 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.9 - 8.68) | Buy |
| Bollinger Bands (100): | (5.04 - 7.24) | Buy |
SLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 42.81 | Sell |
| Chaikin Money Flow: | -689516 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.16 - 1.28) | Sell |
| Bollinger Bands (100): | (1.16 - 1.28) | Sell |
AVXL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.33 | Buy |
| 20-day SMA: | 7.76 | Buy |
| 50-day SMA: | 6.39 | Buy |
| 200-day SMA: | 5.3 | Buy |
| 8-day EMA: | 8.49 | Buy |
| 20-day EMA: | 7.81 | Buy |
| 50-day EMA: | 6.85 | Buy |
| 200-day EMA: | 6.01 | Buy |
SLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.26 | Sell |
| 20-day SMA: | 1.23 | Sell |
| 50-day SMA: | 1.23 | Sell |
| 200-day SMA: | 1.23 | Sell |
| 8-day EMA: | 1.24 | Sell |
| 20-day EMA: | 1.24 | Sell |
| 50-day EMA: | 1.23 | Sell |
| 200-day EMA: | 1.25 | Sell |
Anavex Life Sciences Earnings Growth & AVXL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.13 per share.
SELLAS Life Sciences Group Earnings Growth & SLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.07 per share.
Anavex Life Sciences Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
SELLAS Life Sciences Group Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||